Journal of Leukocyte Biology Myeloid cells, immune suppression, tumor immunology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on June 1, 2007

Published online before print March 8, 2007
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow All Versions of this Article:
jlb.0806516v1
81/6/1535    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gombart, A. F.
Right arrow Articles by Koeffler, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gombart, A. F.
Right arrow Articles by Koeffler, H. P.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0806516


Received for publication August 15, 2006.
Revised January 17, 2007.
Accepted for publication February 6, 2007.


Article

ATF4 differentially regulates transcriptional activation of myeloid-specific genes by C/EBP{varepsilon} and C/EBP{alpha}

Adrian F. Gombart @, Jeffrey Grewal , and H. Phillip Koeffler

Cedars-Sinai Medical Center, Division of Hematology/Oncology, Burns & Allen Research Institute and David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA

@ To whom correspondence should be addressed. E-mail: gombarta{at}csmc.edu.


   Abstract

Dimerization between different basic region leucine zipper (ZIP) transcription factors is regarded as an important mechanism for integrating various extracellular signals to control specific patterns of gene expression in cells. The activating transcription factor 4 (ATF4) protein was identified as a principal partner for the myeloid-specific transcriptional factor C/EBP{varepsilon}. Dimerization required the ZIP motif of each protein and redirected DNA binding of C/EBP{varepsilon} and ATF4 from their respective symmetric consensus sites to asymmetric C/EBP and cAMP response element sites. The C/EBP{varepsilon}:ATF4 heterodimer bound to the C/EBP sites in the promoters of the myeloid-specific genes encoding neutrophil elastase (NE) and the G-CSF receptor (G-CSFR). Also, the heterodimer bound a previously uncharacterized site in the promoter of the mim-1 gene at nucleotide -174. Coexpression of ATF4 and C/EBP{varepsilon} in the presence of c-Myb synergistically activated the mim-1 and NE promoters compared with C/EBP{varepsilon} plus c-Myb alone. Synergistic activation was not observed for the G-CSFR promoter and only occurred in the presence of c-myb with the NE or mim-1 promoters. In contrast, ATF4:C/EBP{alpha} dimers bound to the C/EBP sites in the G-CSFR and NE promoters, but transcriptional activation was inhibited by 30-80% in the presence or absence of c-Myb. We propose that ATF4 may regulate myeloid gene expression differentially by potentiating C/EBP{varepsilon} but inhibiting C/EBP{alpha}-mediated transcriptional activation.

Key Words: CCAAT/enhancer • yeast two-hybrid • activating transcription factor • heterodimer




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
M. Pascual, M. J. Gomez-Lechon, J. V. Castell, and R. Jover
ATF5 Is a Highly Abundant Liver-Enriched Transcription Factor that Cooperates with Constitutive Androstane Receptor in the Transactivation of CYP2B6: Implications in Hepatic Stress Responses
Drug Metab. Dispos., June 1, 2008; 36(6): 1063 - 1072.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. M. Chumakov, A. Silla, E. A. Williamson, and H. P. Koeffler
Modulation of DNA binding properties of CCAAT/enhancer binding protein epsilon by heterodimer formation and interactions with NFkappaB pathway
Blood, May 15, 2007; 109(10): 4209 - 4219.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the Society for Leukocyte Biology.